Langerhans Cell Histiocytosis Expresses Killer Cell Immunoglobulin-Like Receptor 2DL4 (CD158d), a Possible Target of Antibody Therapy

被引：0
|
作者：
Kataoka, Tatsuki R.
Ueshima, Chiyuki
Hirata, Masahiro
Takei, Yusuke
Iwamoto, Sanju
Haga, Hironori
机构：
[1] Kyoto Univ, Kyoto, Japan
[2] Syowa Univ, Sch Med, Tokyo, Japan
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1406
引用
收藏
页码：356A / 356A
页数：1
相关论文
共 50 条
  • [1] Langerhans Cell Histiocytosis Expresses Killer Cell Immunoglobulin-Like Receptor 2DL4 (CD158d), a Possible Target of Antibody Therapy
    Kataoka, Tatsuki R.
    Ueshima, Chiyuki
    Hirata, Masahiro
    Takei, Yusuke
    Iwamoto, Sanju
    Haga, Hironori
    MODERN PATHOLOGY, 2016, 29 : 356A - 356A
  • [2] Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis
    Takei, Yusuke
    Ueshima, Chiyuki
    Kataoka, Tatsuki R.
    Hirata, Masahiro
    Sugimoto, Akihiko
    Rokutan-Kurata, Mariyo
    Moriyoshi, Koki
    Ono, Kazuo
    Murakami, Ichiro
    Iwamoto, Sanju
    Haga, Hironori
    ONCOTARGET, 2017, 8 (23) : 36964 - 36972
  • [3] Killer Immunoglobulin-Like Receptor 2DL4 (CD158d) Regulates Human Mast Cells both Positively and Negatively: Possible Roles in Pregnancy and Cancer Metastasis
    Kataoka, Tatsuki R.
    Ueshima, Chiyuki
    Hirata, Masahiro
    Minamiguchi, Sachiko
    Haga, Hironori
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [4] Prediction and design of small molecule inhibitors of human killer-cell immunoglobulin-like receptor (KIR) 2DL4
    Dakshanamurthy, Sivanesan
    Gedil, Melaku
    Hurley, Carolyn
    Pattabiraman, Nagarajan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [5] The Structure of the Atypical Killer Cell Immunoglobulin-like Receptor, KIR2DL4
    Moradi, Shoeib
    Berry, Richard
    Pymm, Phillip
    Hitchen, Corinne
    Beckham, Simone A.
    Wilce, Matthew C. J.
    Walpole, Nicholas G.
    Clements, Craig S.
    Reid, Hugh H.
    Perugini, Matthew A.
    Brooks, Andrew G.
    Rossjohn, Jamie
    Vivian, Julian P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (16) : 10460 - 10471
  • [6] Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158)
    Long, EO
    Barber, DF
    Burshtyn, DN
    Faure, M
    Peterson, M
    Rajagopalan, S
    Renard, V
    Sandusky, M
    Stebbins, CC
    Wagtmann, N
    Watzl, C
    IMMUNOLOGICAL REVIEWS, 2001, 181 : 223 - 233
  • [7] KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential
    Faure, M
    Long, EO
    JOURNAL OF IMMUNOLOGY, 2002, 168 (12): : 6208 - 6214
  • [8] Genetic polymorphisms of killer cell immunoglobulin-like receptor 3DL2 in preeclampsia
    Wang, Xiao-lan
    Wang, Qi
    Sun, Cheng-juan
    Zhang, Wei-yuan
    JOURNAL OF PERINATAL MEDICINE, 2011, 39 (03) : 273 - 278
  • [9] Endosomal Signaling and a Novel Pathway Defined by the Natural Killer Receptor KIR2DL4 (CD158d)
    Rajagopalan, Sumati
    TRAFFIC, 2010, 11 (11) : 1381 - 1390
  • [10] Killer cell immunoglobulin-like receptor/3DL2 expression in adult T-cell leukaemia
    Obama, Kosuke
    Kubota, Ryuji
    Tara, Mitsutoshi
    Furukawa, Yoshitaka
    Osame, Mitsuhiro
    Arimura, Kimiyoshi
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (05) : 666 - 667
12345